Aduro BioTech

Aduro BioTech

Aduro BioTech

Aduro BioTech is a development-stage biopharmaceutical company engaged in thedevelopment of early-stage cancer therapies.
Type
B2b
Founded
2000
Raised
$125.7M
Follow us
Alexa global traffic share
Latest funding Show all
$51,400,000
Venture capital (Series D) - 2015
Janus Capital Group OrbiMed
$55,000,000
Venture capital (Series C) - 2014
Johnson & Johnson Development Corporation Morningside Group
Team Size
1–10
Employees
GeekWire

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

GeekWire

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

the home of AI info

Reviewing Aduro BioTech Inc. (ADRO)'s and Minerva Neurosciences Inc. (NASDAQ:NERV)'s results

The Motley Fool

Why a Mid-Stage Trial Is Causing Aduro Biotech to Tumble 22% Today

Xconomy

Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound

Health
The Motley Fool

Why Aduro Biotech Is Crashing Today --